Skip to search formSkip to main contentSkip to account menu

Selective Estrogen Receptor Degrader LSZ102

Known as: LSZ102, LSZ 102, SERD LSZ 102 
An selective estrogen receptor (ER) degrader (SERD), with potential antineoplastic activity. Upon administration of LSZ102, this agent binds to the… 
National Institutes of Health

Related topics

Related topics

1 relation
NCIt Antineoplastic Agent Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract OT1-03-01: Phase 1/1b study of novel oral selective estrogen receptor degrader (SERD) LSZ102 in combination with alpelisib (BYL719) in estrogen receptor-positive (ER+), human epidermal…
Background: Although ET remains the basis of therapy for ER+, HER2– ABC, treatment resistance frequently occurs. Novel strategies… 
2013
2013
[Alcohol-addiction inpatient: characteristics of patients and rehabilitation program].
AIM The treatment of alcohol addiction in Italy has had a progressive evolution of therapeutic structures for in-and outpatients… 
2011
2011
ENTREGA DE GAFAS EN TRES COMUNIDADES DE PUEBLA
RESENA DE LA JORNADA POR LA SALUD QUE LA UNAM REALIZO EN EL ESTADO DE PUEBLA. EN EL EVENTO, LA DIRECCION GENERAL DE ORIENTACION Y… 
2006
2006
Применение универсального инструментария lsz при сколиозе у пациентов с незавершенным и завершенным ростом позвоночника
In work is offered the new method of surgical treatment of idiopathic scoliosis III-IV of degree at patients with the unfinished… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)